| Benefit of adjuvant chemotherapy for resectable gastric cancer a meta-analysis X Paoletti, K Oba, T Burzykowski, S Michiels, Y Ohashi, JP Pignon, ... AMER MEDICAL ASSOC, 2010 | 944 | 2010 |
| Towards a pan-European consensus on the treatment of patients with colorectal liver metastases E Van Cutsem, B Nordlinger, R Adam, CH Köhne, C Pozzo, G Poston, ... European journal of cancer 42 (14), 2212-2221, 2006 | 803 | 2006 |
| Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients C Pozzo, M Basso, A Cassano, M Quirino, G Schinzari, N Trigila, ... Annals of Oncology 15 (6), 933-939, 2004 | 421 | 2004 |
| Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a … C Pozzo, C Barone, J Szanto, E Padi, C Peschel, J Bükki, V Gorbunova, ... Annals of Oncology 15 (12), 1773-1781, 2004 | 231 | 2004 |
| Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases C Barone, G Nuzzo, A Cassano, M Basso, G Schinzari, F Giuliante, ... British journal of cancer 97 (8), 1035-1039, 2007 | 155 | 2007 |
| Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial S Cascinu, R Labianca, C Barone, A Santoro, C Carnaghi, A Cassano, ... Journal of the National Cancer Institute 99 (8), 601-607, 2007 | 134 | 2007 |
| Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: a systematic review and meta-analysis E Rinninella, M Cintoni, P Raoul, C Pozzo, A Strippoli, E Bria, G Tortora, ... Clinical Nutrition 39 (7), 2045-2054, 2020 | 106 | 2020 |
| Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2‐gastrectomy R Persiani, D D'Ugo, S Rausei, D Sermoneta, C Barone, C Pozzo, R Ricci, ... Journal of surgical oncology 89 (4), 227-236, 2005 | 97 | 2005 |
| Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research International ... Jama 303 (17), 1729-1737, 2010 | 92 | 2010 |
| Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy G Nuzzo, F Giuliante, F Ardito, M Vellone, C Pozzo, A Cassano, ... Journal of Gastrointestinal Surgery 11 (3), 318-324, 2007 | 89 | 2007 |
| Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents? C Pozzo, C Barone The oncologist 13 (7), 794-806, 2008 | 71 | 2008 |
| Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials E Rinninella, M Cintoni, P Raoul, C Pozzo, A Strippoli, E Bria, G Tortora, ... Clinical nutrition ESPEN 38, 28-42, 2020 | 69 | 2020 |
| Irinotecan in combination with CDDP or 5-FU and folinic acid is active in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma: final results of a … C Pozzo Proc ASCO 20, 134, 2001 | 68 | 2001 |
| Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer C Barone, M Basso, G Schinzari, C Pozzo, N Trigila, E D'Argento, ... Gastric cancer 10, 104-111, 2007 | 61 | 2007 |
| Critical appraisal of ramucirumab (IMC-1121B) for cancer treatment: from benchside to clinical use G Aprile, M Bonotto, E Ongaro, C Pozzo, F Giuliani Drugs 73, 2003-2015, 2013 | 58 | 2013 |
| Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer IV Zurlo, M Schino, A Strippoli, MA Calegari, A Cocomazzi, A Cassano, ... Cancer Immunology, Immunotherapy 71 (1), 45-55, 2022 | 56 | 2022 |
| A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer E Van Cutsem, C Pozzo, H Starkhammar, L Dirix, E Terzoli, F Cognetti, ... Annals of oncology 9 (11), 1199-1204, 1998 | 53 | 1998 |
| Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5 … D Curran, C Pozzo, J Zaluski, M Dank, C Barone, V Valvere, S Yalcin, ... Quality of Life Research 18, 853-861, 2009 | 52 | 2009 |
| Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer C Barone, A Cassano, C Pozzo, D D’Ugo, G Schinzari, R Persiani, ... Oncology 67 (1), 48-53, 2004 | 50 | 2004 |
| Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer DC Corsi, M Ciaparrone, G Zannoni, M Mancini, A Cassano, M Specchia, ... European journal of cancer 38 (4), 527-534, 2002 | 48 | 2002 |
